Evidence map›Paper›PMID 35454870›Full record

ArticleCancers2022

Prospective Real-World Gynaecological Cancer Clinical Registry with Associated Biospecimens: A Collaborative Model to Promote Translational Research between GEICO and the Spanish Biobank Network.

José Antonio López-Guerrero, Marta Mendiola, José Alejandro Pérez-Fidalgo, Ignacio Romero, Ana Torres, Delia Recalde, Elena Molina, César Gómez-Raposo, Ana M Levin, Ana Herrero and 11 more

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 6 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 16 institutions in 1 country.

José Antonio López-GuerreroLaboratorio de Biología Molecular y Biobanco, Fundación Instituto Valenciano de Oncología, 46009 Valencia, Spain.ORCID 0000-0002-7369-8388
Marta MendiolaLaboratorio de Patología Molecular y Dianas Terapéuticas, Instituto de Investigación Hospital Universitario La Paz (IdiPAZ), 28029 Madrid, Spain.
José Alejandro Pérez-FidalgoDepartamento de Oncología Médica, Hospital Clinico de Valencia, Instituto de Investigación Sanitaria INCLIVA, Universidad de Valencia, CIBERONC, 46010 Valencia, Spain.ORCID 0000-0003-3568-4345
Ignacio RomeroDepartment of Medical Oncology, Fundación Instituto Valenciano de Oncología, 46009 Valencia, Spain.
Ana TorresBiobanco del Hospital Universitario Ramón y Cajal, 28034 Madrid, Spain.
Delia RecaldeBiobanco del Sistema de Salud de Aragón, 50009 Zaragoza, Spain.
Elena MolinaBiobanco del Hospital Clínico San Carlos, 28040 Madrid, Spain.ORCID 0000-0002-8882-8405
César Gómez-RaposoDepartment of Medical Oncology, Hospital Universitario Infanta Sofía, 28703 Madrid, Spain.
Ana M LevinGrupo Español de Investigación en Cáncer de Ovario, 28003 Madrid, Spain.
Ana HerreroDepartment of Medical Oncology, Hospital Universitario Miguel Servet, 50009 Zaragoza, Spain.
Jesús AlarcónDepartment of Medical Oncology, Hospital Universitario Son Espases, 07120 Palma, Spain.
Carmen EstebanDepartment of Medical Oncology, Hospital Virgen de la Salud, 45004 Toledo, Spain.ORCID 0000-0002-3986-9665
Gloria MarquinaDepartment of Medical Oncology, Hospital Clínico San Carlos, 28040 Madrid, Spain.ORCID 0000-0002-8961-9787
María Jesús RubioDepartment of Medical Oncology, Hospital Universitario Reina Sofía, 14004 Córdoba, Spain.ORCID 0000-0003-3682-3597
Eva GuerraDepartment of Medical Oncology, Hospital Universitario Ramón y Cajal, 28034 Madrid, Spain.
Luisa Sánchez-LorenzoDepartment of Medical Oncology, Clínica Universidad de Navarra, 28027 Madrid, Spain.ORCID 0000-0001-9139-6730
Fernando Gálvez-MontosaDepartment of Medical Oncology, Hospital Universitario de Jaén, 23007 Jaén, Spain.
Ana de JuanDepartment of Medical Oncology, Hospital Univeristario Marqués de Valdecilla, 39008 Santander, Spain.
Cristina ChurrucaDepartment of Medical Oncology, Hospital Universitario Donostia, 20014 Donostia, Spain.
Alejandro GallegoDepartment of Medical Oncology, Hospital Universitario La Paz, 28029 Madrid, Spain.
Antonio González-MartínDepartment of Medical Oncology, Clínica Universidad de Navarra, 28027 Madrid, Spain.
Clinica Universidad de Navarra · ESHospital Clínico San Carlos · ESHospital Universitario La Paz · ESHospital Universitario Ramón y Cajal · ESComplejo Hospitalario de Jaén · ESFundación Instituto Valenciano de Oncología · ESHospital Universitario Infanta Sofía · ESHospital Universitario Miguel Servet · ESHospital Universitario Reina Sofía · ESHospital Universitario Son Espases · ESHospital Virgen de la Salud · ESMarqués de Valdecilla University Hospital · ESServicio Aragonés de Salud · ESSpanish Ovarian Cancer Research Group · ESUniversitat de València · ESValencia Catholic University Saint Vincent Martyr · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Patient registries linked to biorepositories constitute a valuable asset for clinical and translational research in oncology. The Spanish Group of Ovarian Cancer Research (GEICO), in collaboration with the Spanish Biobank Network (RNBB), has developed a multicentre, multistakeholder, prospective virtual clinical registry (VCR) associated with biobanks for the collection of real-world data and biological samples of gynaecological cancer patients. This collaborative project aims to promote research by providing broad access to high-quality clinical data and biospecimens for future research according to the needs of investigators and to increase diagnostic and therapeutic opportunities for gynaecological cancer patients in Spain. The VCR will include the participation of more than 60 Spanish hospitals entering relevant clinical information in harmonised electronic case report forms (eCRFs) in four different cohorts: ovarian, endometrial, cervical, and rare gynaecological cancers (gestational trophoblastic disease). Initial data for the cases included till December 2021 are presented. The model described herein establishes a real-world win-win collaboration between multicentre structures, promoted and supported by GEICO, that will contribute to the success of translational research in gynaecological cancer.

Indexed as

biobankingbiospecimensgynaecological cancerharmonisationpatient registrytranslational research

Identifiers

PMID35454870
PMCPMC9031046
OpenAlexW4224093375

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.